Home
Storia in 1 fonti
Aurobindo Pharma edges past Dr Reddy’s in FY26 revenue race
Aurobindo Pharma surpasses Dr Reddy's in FY26 revenue, becoming the second-largest Indian pharma company.
Raccontata da
thehindubusinessline.com
Timeline cronologica
- ·
Aurobindo Pharma’s Q4 net up 2% to ₹921 crore
Aurobindo Pharma reports a 2% net profit rise to ₹921 crore with total revenue growing 5.6% to ₹8,853 crore in Q4.
- ·
Aurobindo Pharma edges past Dr Reddy’s in FY26 revenue race
Aurobindo Pharma surpasses Dr Reddy's in FY26 revenue, becoming the second-largest Indian pharma company.